The subcutaneous implantable cardioverter defibrillator—— review of the recent data

作     者：Stacy B Westerman Mikhael El-Chami 

作者机构：Emory University School of Medicine Atlanta USA Division of Cardiology Section of Electrophysiology Emory University School of Medicine Atlanta USA 

出 版 物：《Journal of Geriatric Cardiology》 (老年心脏病学杂志（英文版）)

年 卷 期：2018年第15卷第3期

页      面：222-228页

核心收录：

学科分类：0710[理学-生物学] 080706[工学-化工过程机械] 07[理学] 08[工学] 0807[工学-动力工程及工程热物理] 071003[理学-生理学] 

主　　题：Inappropriate shocks Subcutaneous ICD Sudden Cardiac death Transvenous ICD 

摘      要：The subcutaneous implantable cardioverter defibrillators （SICD） is an altemative to the transvenous ICD for the prevention of sudden cardiac death （SCD）. Multiple studies have shown that the SICD is safe and effective in treating ventricular arrhythmias. While earlier stud- ies mainly enrolled younger patients with channelopathies, more recent reports included patients with ＂typical＂ indications for ICD therapy for the prevention of SCD. In this review we summarize the data available to date on the SICD while highlighting its pros and cons.